Skip to content

Clinical trials

Hyperlipidemias trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: Germany Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20044
20053
20062
20071
20081
20092
20101
20111
20121
20138
20161
20171
20181
20221
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Novartis Pharmaceuticals4
Pfizer4
Takeda4
AstraZeneca2
Solvay Pharmaceuticals2
89bio, Inc.1
Akcea Therapeutics1
Bayer1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias35
Hypercholesterolemia11
Dyslipidemias9
Cardiovascular Diseases7
Diabetes Mellitus5
Diabetes Mellitus, Type 24
Atherosclerosis3
Aortic Valve Stenosis2
Coronary Disease2
Heart Failure2

Trials

Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.